RxSight, Inc.
RXST · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$27,455 | -$48,608 | -$66,756 | -$48,688 |
| Dep. & Amort. | $3,624 | $4,243 | $4,022 | $3,988 |
| Deferred Tax | $0 | $0 | $0 | -$5,398 |
| Stock-Based Comp. | $24,635 | $15,746 | $11,397 | $7,575 |
| Change in WC | -$9,211 | -$9,072 | -$7,412 | -$2,678 |
| Other Non-Cash | -$8,539 | -$3,902 | -$101 | $493 |
| Operating Cash Flow | -$16,946 | -$41,593 | -$58,850 | -$44,708 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$5,440 | -$4,814 | -$2,393 | -$1,940 |
| Net Acquisitions | $0 | $17,315 | -$42,343 | $79,967 |
| Inv. Purchases | -$336,871 | -$272,315 | -$212,657 | -$159,967 |
| Inv. Sales/Matur. | $243,000 | $255,000 | $255,000 | $80,000 |
| Other Inv. Act. | $0 | -$17,315 | $42,343 | -$79,967 |
| Investing Cash Flow | -$99,311 | -$22,129 | $39,950 | -$81,907 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$61 | -$40,153 | -$121 | $14,973 |
| Stock Issued | $128,916 | $105,957 | $7,828 | $121,136 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$5,536 | -$4,280 | -$1,375 | $1,233 |
| Financing Cash Flow | $123,319 | $61,524 | $6,332 | $137,342 |
| Forex Effect | -$9 | $6 | -$9 | -$10 |
| Net Chg. in Cash | $7,053 | -$2,192 | -$12,577 | $10,717 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $10,403 | $12,595 | $25,172 | $14,455 |
| End Cash | $17,456 | $10,403 | $12,595 | $25,172 |
| Free Cash Flow | -$22,386 | -$46,407 | -$61,243 | -$46,648 |